Mark Moyer and Abby Proch A conversation between Immunocore Chief Regulatory and Quality Officer Mark Moyer and Clinical Leader Executive Editor Abby Proch The first thresholds for , based somewhat crudely on how researchers measure simulated tumor masses sandwiched between a layer of foam and a mattress. It’s true. In the 50 years since, the approach has evolved into what we now call Response Evaluation Criteria in Solid Tumors, or RECIST.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Mark
Contact Mark, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack